Chemoinformaics analysis of 2,3,5,6-Tetramethylphenol
| Molecular Weight | 150.221 | nRot | 0 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 1 |
| Exact Molecular Weight | 150.104 | nRing | 1 |
| Solubility: LogS | -2.635 | nHRing | 0 |
| Solubility: LogP | 3.155 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 26.8371 |
| nHD | 1 | BPOL | 14.0449 |
| QED | 0.586 |
| Synth | 2.951 |
| Natural Product Likeliness | 1.976 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.213 |
| MDCK | 0.000022 |
| BBB | 0.99 |
| PPB | 0.55645 |
| VDSS | 1.098 |
| FU | 0.515102 |
| CYP1A2-inh | 0.421 |
| CYP1A2-sub | 0.701 |
| CYP2c19-inh | 0.064 |
| CYP2c19-sub | 0.424 |
| CYP2c9-inh | 0.039 |
| CYP2c9-sub | 0.701 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.287 |
| CYP3a4-inh | 0.015 |
| CYP3a4-sub | 0.17 |
| CL | 9.493 |
| T12 | 0.623 |
| hERG | 0.013 |
| Ames | 0.005 |
| ROA | 0.008 |
| SkinSen | 0.627 |
| Carcinogencity | 0.58 |
| EI | 0.986 |
| Respiratory | 0.048 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.861459 |